CME TTR Amyloidosis Treating and Empowering the Patient Mo Mori - - PowerPoint PPT Presentation

cme ttr amyloidosis
SMART_READER_LITE
LIVE PREVIEW

CME TTR Amyloidosis Treating and Empowering the Patient Mo Mori - - PowerPoint PPT Presentation

CME TTR Amyloidosis Treating and Empowering the Patient Mo Mori rie A Gert rtz, z, MD MD: Ma Mayo Clinic Treatment Options Symptom relief Liver transplantation TTR stabilizers Tafamidis Diflunisal Tetramer Monomer


slide-1
SLIDE 1

CME TTR Amyloidosis

Treating and Empowering the Patient Mo Mori rie A Gert rtz, z, MD MD: Ma Mayo Clinic

slide-2
SLIDE 2

Treatment Options

Tetramer Monomer Misfolded protein Amyloid fibrils

  • Symptom relief
  • Liver transplantation
  • TTR stabilizers
  • Tafamidis
  • Diflunisal
  • TTR production blockers
  • Inotersen
  • Patisiran
slide-3
SLIDE 3

Managing TTR Amyloidosis is a Team Effort

Educating Patients

  • Long-term management
  • Compliance

Team approach to care

  • Cardiologists
  • Nephrologists
  • Neurologists
  • Gastrointestinal specialists
  • Ophthalmologists
  • Genetic counselors
  • General practitioners
  • Nurses
slide-4
SLIDE 4

amyloidosissupport.org

  • Treatment centers
  • Local chapters
  • Events
  • New
  • Resources
  • Clinical trail Information
  • Amyloidosis information

Amyloidosis Support Groups

slide-5
SLIDE 5

arci.org

  • Research
  • Events
  • Treatment centers
  • Patient support resources
  • Clinical trail Information
  • Amyloidosis information
  • My Amyloidosis Pathfinder

(MAP)

Amyloidosis Research Consortium

slide-6
SLIDE 6

amyloidosis.org

  • Facts
  • Research
  • Toolkits
  • Webinars
  • Support material
  • Stories

Amyloidosis Foundation

slide-7
SLIDE 7

TTR Amyloidosis is:

  • No longer a death sentence
  • Manageable and treatable
  • Rare but not as rare as we

assume

  • Awareness campaigns are

available

  • Support is available

Summary

@moriegertz